Business Standard Lupin signs exclusive India pact with Gan & Lee for fortnightly GLP-1 drug
Lupin has signed an exclusive licensing, supply and distribution deal with China's Gan & Lee for Bofanglutide, a fortnightly GLP-1 injectable for diabetes and weight management in India